Free Float 68,60 %
Shares Float 23,6 M
Shares Outstanding 34,41 M
ULTIMOVACS AS DK1
Share · NO0010851603 · A2PKSD (XOSL)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ULTIMOVACS AS DK1
No Price
Share Float & Liquidity
Company Profile for ULTIMOVACS AS DK1 Share
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.
Company Data
Name ULTIMOVACS AS DK1
Company Ultimovacs ASA
Website
https://ultimovacs.com
Primary Exchange 
OSLO BORS
OSLO BORS
WKN A2PKSD
ISIN NO0010851603
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Hans Vassgard Eid
Market Capitalization 71 Mio
Country Norway
Currency EUR
Employees 0,0 T
Address Ullernchausséen 64, 0379 Oslo
IPO Date 2019-06-03
Ticker Symbols
| Name | Symbol |
|---|---|
| OSLO BORS | ULTI.OL |
| Frankfurt | 7UM.F |
More Shares
Investors who hold ULTIMOVACS AS DK1 also have the following shares in their portfolio:
